Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02899598Withdrawn
Open-label, single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Number of Fetomaternal platelet incompatibilities detected at 30 months. Planned start Jul 2023; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02899598.